CLS Holdings USA, Inc. (CLSH) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
$'dan işlem gören CLS Holdings USA, Inc. (CLSH), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 43/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 17 Mar 2026CLS Holdings USA, Inc. (CLSH) Sağlık ve Boru Hattı Genel Bakışı
CLS Holdings USA, Inc. operates in the cannabis industry, focusing on the extraction and conversion of cannabinoids into various products. The company sells to licensed retailers and distributors under the Oasis Cannabis and City Trees brands, offering concentrates, edibles, and consulting services within the United States.
Yatırım Tezi
CLS Holdings USA, Inc. presents a speculative investment opportunity within the cannabis sector, characterized by its focus on extraction and branded product sales. With a market capitalization of $0.01 billion and a negative P/E ratio of -16.20, the company's financial performance indicates challenges in achieving profitability. A gross margin of 41.4% suggests potential for operational efficiency, but the negative profit margin of -4.6% highlights the need for improved cost management. Growth catalysts include expansion of its product lines and increased market penetration in existing and new geographic areas. However, investors may want to evaluate the risks associated with the OTC market, regulatory uncertainties, and competition within the cannabis industry. The company's beta of 1.18 indicates higher volatility compared to the overall market.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $0.01 billion reflects the company's small size and potential for growth or volatility.
- Gross margin of 41.4% indicates a reasonable level of efficiency in production and sales.
- Negative P/E ratio of -16.20 suggests the company is currently not profitable.
- Profit margin of -4.6% highlights the need for improved cost management and revenue generation.
- Beta of 1.18 indicates the stock is more volatile than the overall market.
Rakipler & Benzerleri
Güçlü Yönler
- Diversified cannabis product offerings.
- Established brands (Oasis Cannabis and City Trees).
- Expertise in cannabinoid extraction and conversion.
- Provision of consulting services.
Zayıflıklar
- Small market capitalization.
- Negative profitability.
- Limited geographic reach.
- Reliance on the regulatory environment in specific states.
Katalizörler
- Upcoming: Potential changes in cannabis regulations at the state or federal level could create new market opportunities.
- Ongoing: Expansion of the company's product lines to include new cannabis-infused products.
- Ongoing: Strategic partnerships with other cannabis companies to expand market reach.
- Ongoing: Increased focus on branding and marketing to drive customer awareness and loyalty.
Riskler
- Ongoing: Intense competition in the cannabis industry could pressure margins and market share.
- Potential: Fluctuations in cannabis prices could impact revenue and profitability.
- Ongoing: Changing regulatory landscape could create uncertainty and compliance costs.
- Potential: Limited access to capital could hinder growth initiatives.
- Ongoing: Risks associated with operating on the OTC market, including lower liquidity and higher volatility.
Büyüme Fırsatları
- Expansion of Product Lines: CLS Holdings has the opportunity to expand its product lines to include new cannabis-infused products, catering to evolving consumer preferences. The market for cannabis edibles and concentrates is projected to grow significantly, offering potential for increased revenue. By introducing innovative products and formulations, CLS Holdings can attract new customers and increase its market share. This expansion could involve developing new flavors, dosages, or delivery methods, such as vape pens or topical creams. The timeline for this growth opportunity is immediate, with ongoing product development efforts.
- Geographic Expansion: CLS Holdings can pursue geographic expansion by entering new markets and establishing operations in states with favorable cannabis regulations. The cannabis market is expanding across the United States, with more states legalizing medical and recreational use. By strategically targeting new markets, CLS Holdings can increase its customer base and revenue streams. This expansion could involve establishing new cultivation facilities, processing plants, or retail locations. The timeline for this growth opportunity is medium-term, with potential for expansion over the next 2-3 years.
- Strategic Partnerships: CLS Holdings can form strategic partnerships with other cannabis companies, including cultivators, distributors, and retailers, to expand its reach and market presence. These partnerships can provide access to new markets, technologies, and resources, enabling CLS Holdings to accelerate its growth. For example, CLS Holdings could partner with a large-scale cultivator to secure a reliable supply of cannabis or with a retail chain to distribute its products. The timeline for this growth opportunity is ongoing, with potential for partnerships to be formed at any time.
- Increased Focus on Branding: CLS Holdings can invest in branding and marketing efforts to increase awareness of its Oasis Cannabis and City Trees brands and differentiate its products from competitors. A strong brand can create customer loyalty and increase sales. This could involve developing a consistent brand identity, launching marketing campaigns, and engaging with customers through social media and events. The timeline for this growth opportunity is ongoing, with continuous efforts to build brand awareness and loyalty.
- Development of Proprietary Strains: CLS Holdings can develop proprietary cannabis strains with unique characteristics and effects, creating a competitive advantage in the market. Proprietary strains can command premium prices and attract customers seeking specific experiences. This could involve investing in research and development to breed new strains with desired traits, such as high potency, unique flavors, or specific medical benefits. The timeline for this growth opportunity is long-term, with potential for new strains to be developed over the next 3-5 years.
Fırsatlar
- Expansion into new geographic markets.
- Development of new cannabis-infused products.
- Strategic partnerships with other cannabis companies.
- Increased focus on branding and marketing.
Tehditler
- Intense competition in the cannabis industry.
- Changing regulatory landscape.
- Fluctuations in cannabis prices.
- Limited access to capital.
Rekabet Avantajları
- Established brands (Oasis Cannabis and City Trees).
- Expertise in cannabinoid extraction and conversion.
- Relationships with licensed retailers and distributors.
- Consulting services provide additional revenue streams and customer relationships.
CLSH Hakkında
CLS Holdings USA, Inc., founded in 2014 and based in Las Vegas, Nevada, operates as a diversified cannabis company specializing in the extraction and conversion of cannabinoids. The company's core business involves extracting cannabinoids from cannabis plants and transforming them into concentrates such as oils, waxes, edibles, and shatters. These products are marketed under the Oasis Cannabis and City Trees brand names. CLS Holdings serves licensed retailers and distributors, offering organic medical cannabis and recreational marijuana cannabis products. In addition to its branded product lines, CLS Holdings provides extraction services for licensed medical cannabis cultivators and sells cannabis strains in vegetative cuttings. The company also offers consulting services to cannabis-related businesses, including growers, dispensaries, and laboratories, as well as toll processing services. CLS Holdings' concentrates are utilized for both pharmaceutical and other purposes, demonstrating the company's diversified approach within the cannabis market.
Ne Yaparlar
- Extracts cannabinoids from cannabis plants.
- Converts cannabinoids into concentrates like oils, waxes, and edibles.
- Sells organic medical cannabis to licensed retailers.
- Sells recreational marijuana cannabis products to licensed distributors and retailers.
- Offers extraction products derived from in-house cannabis production.
- Provides processing and extraction services for licensed medical cannabis cultivators.
- Sells cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators.
- Offers consulting services to cannabis-related businesses.
İş Modeli
- Extraction and conversion of cannabinoids into various products.
- Sales of branded cannabis products under Oasis Cannabis and City Trees.
- Provision of extraction and processing services to other cannabis businesses.
- Consulting services for cannabis-related businesses.
Sektör Bağlamı
CLS Holdings USA, Inc. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is characterized by increasing acceptance of cannabis for both medical and recreational use, driving demand for various cannabis products. CLS Holdings competes with other cannabis companies, including ACRDF, ACRHF, BCBCF, CHNC, and FFLWF, focusing on extraction, product development, and distribution. The industry faces regulatory hurdles, varying state laws, and intense competition, requiring companies to adapt and innovate to maintain a competitive edge. Market trends include the increasing popularity of cannabis concentrates and edibles, as well as the expansion of cannabis retail networks.
Kilit Müşteriler
- Licensed cannabis retailers.
- Licensed cannabis distributors.
- Licensed medical cannabis cultivators.
- Cannabis-related businesses (growers, dispensaries, laboratories).
Finansallar
Grafik & Bilgi
CLS Holdings USA, Inc. (CLSH) hisse senedi fiyatı: Price data unavailable
Son Haberler
-
Stocks That Hit 52-Week Lows On Tuesday
· 24 Mar 2020
-
Stocks That Hit 52-Week Lows On Thursday
· 27 Şub 2020
-
Stocks That Hit 52-Week Lows On Thursday
· 20 Şub 2020
-
New 52-Week Lows for Tuesday Morning
· 30 Tem 2019
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
CLSH için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
CLSH için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, CLSH'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: Andrew J. Glashow
CEO
Andrew J. Glashow serves as the CEO of CLS Holdings USA, Inc., leading the company's strategic direction and operations. His background includes experience in managing teams and driving growth within the cannabis industry. He is responsible for overseeing the company's extraction, production, and sales activities, as well as its consulting services. Glashow's leadership is focused on expanding CLS Holdings' market presence and developing innovative cannabis products. His expertise in the cannabis sector is pivotal to navigating the complex regulatory landscape and capitalizing on growth opportunities.
Sicil: Under Andrew J. Glashow's leadership, CLS Holdings has focused on expanding its product lines and increasing its market share in the cannabis industry. He has overseen the development and launch of new cannabis-infused products, as well as the expansion of the company's consulting services. His strategic decisions have aimed at improving operational efficiency and driving revenue growth. However, the company's profitability remains a challenge.
CLSH OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for quotation on OTCQX or OTCQB. These securities may include those of companies that are unwilling or unable to meet the financial reporting standards or other requirements for higher tiers. Companies on the OTC Other tier may have limited information available to investors, and trading in these securities can be highly speculative. This tier often includes defunct companies, shell corporations, and companies with questionable business practices.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited information availability due to lower disclosure requirements.
- Higher potential for fraud and manipulation.
- Lower liquidity and wider bid-ask spreads.
- Greater price volatility.
- Increased risk of delisting or company failure.
- Verify the company's financial reporting status and access any available financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review any available news articles or press releases about the company.
- Check for any regulatory filings or legal proceedings involving the company.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before making any investment decisions.
- The company has been in operation since 2014.
- The company has established brands (Oasis Cannabis and City Trees).
- The company has a team of 80 employees.
- The company provides extraction and consulting services, indicating some level of expertise.
CLSH Healthcare Hisse Senedi SSS
CLSH için değerlendirilmesi gereken temel faktörler nelerdir?
CLS Holdings USA, Inc. (CLSH) şu anda yapay zeka skoru 43/100, düşük puanı gösteriyor. Temel güçlü yan: Diversified cannabis product offerings.. İzlenmesi gereken birincil risk: Ongoing: Intense competition in the cannabis industry could pressure margins and market share.. Bu bir finansal tavsiye değildir.
CLSH MoonshotScore'u nedir?
CLSH şu anda MoonshotScore'da 43/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
CLSH verileri ne sıklıkla güncellenir?
CLSH fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler CLSH hakkında ne diyor?
CLSH için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
CLSH'a yatırım yapmanın riskleri nelerdir?
CLSH için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition in the cannabis industry could pressure margins and market share.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
CLSH'ın P/E oranı nedir?
CLSH için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CLSH'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
CLSH aşırı değerli mi, yoksa düşük değerli mi?
CLS Holdings USA, Inc. (CLSH)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
CLSH'ın temettü verimi nedir?
CLS Holdings USA, Inc. (CLSH) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Information is based on available sources and may be subject to change.
- OTC stocks carry higher risks than exchange-listed stocks.
- AI analysis is pending and may provide additional insights.